#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cystic fibrosis respiratory infection suppression Pulmonary hypertension Tourette's disorder Gastric cancer Thrombotic microangiopathy Burkitt's lymphoma Usher's syndrome Duchenne muscular dystrophy Familial amyotrophic lateral sclerosis Exudative retinopathy NTRK gene fusion overexpression Porphyria non-acute Haematological malignancy Hereditary ataxia Plasma cell myeloma refractory More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Trials in Disease Nephroblastoma – Diagnostics Toxic epidermal necrolysis – Basic Information Cytokine release syndrome – Basic Information Synovial sarcoma metastatic – Basic Information Haemophilia – Treatment Hepatic angiosarcoma – Treatment Angiosarcoma – Basic Information Primary hyperoxaluria – Trials in Disease Leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Inavolisib Bp1.7881A FRUQUINTINIB Upacicalcet Sodium Hydrate Denosumab Meropenem Trihydrate D-Camphor RIKKUNSHITO Fipaxalparant Dalteparin Sodium Seralutinib Carbamazepine Ima402 Iron Sucrose Sotrovimab Piracetam Bidridistrogene Xeboparvovec Ibutamoren Mesilate Aavanc80-5'Hotof Camlipixant More therapies…

    Learn about Your Condition

    Neuromyopathy Pancoast's tumour Hypertriglyceridaemia Diabetic ketoacidosis Hepatic cirrhosis Skin wrinkling Mucosal inflammation B-cell lymphoma Type V hyperlipidaemia Bladder cancer stage III Small intestine adenocarcinoma Neurodegenerative disorder Thrombectomy Hydrocele Palmoplantar pustulosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Feasibility, Tolerability and Adherence of Alternate-Day Ferrous Sulfate (Duroferon) in Adolescent Girls With Iron Deficiency

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Iron deficiency
    Investigated Drugs:
    • Ferrous Sulfate
    Sweden

  • Comparing human normal immunoglobulin (iv) and a drug combination to prevent infections in adults with B-cell acute lymphoblastic leukemia or B-cell lymphoma treated with CAR-T cells

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    • B-cell lymphoma
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Azithromycin
    • Levofloxacin
    France

  • Efficacy and Safety of Clemastine Fumarate in Children and Adults with Pitt‑Hopkins Syndrome: A Randomized Placebo‑Controlled Trial

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Clemastine Fumarate
    The Netherlands

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic foot
    • Osteomyelitis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Cefalexin Monohydrate
    • Flucloxacillin
    Finland

  • A study to evaluate the safety and effectiveness of BMS-986523 alone or in combination with a drug combination for patients with advanced solid tumors and KRAS alterations.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Spain

  • Study of the efficacy and safety of ladarixin and rabbit anti-human thymocyte immunoglobulin in adolescents and adults with new-onset type 1 diabetes

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Ladarixin
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    Italy
Previous Page
1 … 723 724 725 726 727 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!